References
- Williams H, Stewart A, von Mutius E, Cookson W, Anderson HR. Is eczema really on the increase worldwide? J Allergy Clin Immunol. 2008;121(4):947–954. doi:10.1016/j.jaci.2007.11.00418155278
- Kownacki S. The importance of emollients in treating the increasing incidence of atopic eczema. Nurs Times. 2009;105:28.
- Clark C. How to chose a suitable emollient? Pharm J. 2004;273:351–353.
- Cork MJ, Danby S. Skin barrier breakdown: a renaissance in emollient therapy. Br J Nurs. 2009;18(14):872–877. doi:10.12968/bjon.2009.18.14.4335619633599
- NICE. Management of Atopic Eczema in Children from Birth up to the Age of 12 Years. National Institute for Health and Clinical Excellence; 2007 Available from: https://www.nice.org.uk/guidance/cg57/resources/atopic-eczema-in-under-12s-diagnosis-and-management-pdf-975512529349. Accessed July 9, 2019.
- Rawlings AV, Canestrari DA, Dobkowski B. Moisturizer technology versus clinical performance. Dermatol Ther. 2004;17:49–56. doi:10.1111/dth.2004.17.issue-s114728699
- NICE. Guidance on use of topical corticosteroids in atopic eczema. Nurs Times. 2004;38:26–27.
- Chase EP, Armstrong AW. Advances in management of atopic dermatitis: new therapies and novel uses of existing treatments. Semin Cutan Med Surg. 2012;31:17–24. doi:10.1016/j.sder.2011.11.00522361285
- Lucky AW, Leach AD, Laskarzewski P, Wenck H. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol. 1997;14:321–324.9263319
- Darsow U, Wollenberg A, Simon D, et al. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. JADV. 2010;24:317–328.
- Drugs, Therapeutics, Bulletin. Topical steroids for atopic dermatitis in primary care. Drug Ther Bull. 2003;41:5–8.12611357
- NICE. Frequency of Application of Topical Corticosteroids for Atopic Eczema. National Institute for Health and Clinical Excellence; 2004 Available from: https://www.nice.org.uk/guidance/ta81/resources/frequency-of-application-of-topical-corticosteroids-for-atopic-eczema-pdf-2294813945797. Accessed July 9, 2019.
- De Belilovsky C, Roo-Rodriguez E, Baudouin C, et al. Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis. J Dermatolog Treat. 2011;22:359–365. doi:10.3109/09546634.2010.49993220964572
- Msika P, De Belilovsky C, Piccardi N, et al. New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improvement. Pediatr Dermatol. 2008;25:606–612. doi:10.1111/j.1525-1470.2008.00783
- Namazi MR. Nicotinamide: a potential addition to the anti-psoriatic weaponry. Faseb J. 2003;17:1377–1379. doi:10.1096/fj.03-0002hyp12890690
- Chen AC, Damian DL. Nicotinamide and the skin. Australas J Dermatol. 2014;55:169–175. doi:10.1111/ajd.1216324635573
- Levine D, Even-Chen Z, Lipets I, et al. Pilot, multicenter, double-blind, randomized placebo-controlled bilateral comparative study of a combination of calcipotriene and nicotinamide for the treatment of psoriasis. J Am Acad Dermatol. 2010;63:775–781. doi:10.1016/j.jaad.2009.10.01620599292
- Siadat AH, Siadat A, Iraji F, Jary M. Topical nicotinamide in combination with calcipotriol for the treatment of mild to moderate psoriasis: a double-blind, randomized, comparative study. Adv Biomed Res. 2013;2:90. doi:10.4103/2277-9175.12252024520552